Tafbin 25mg. 200mg Tablet
PDF Leaflet Revision Date: 25 May 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV-1 infection.
Dosage (summary)
200 mg emtricitabine and 25 mg tenofovir alafenamide once daily for adults and adolescents.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding due to potential harm.
Key Drug Interactions
- Anticonvulsants
- Antimycobacterials
- St. John's wort
Contraindications
- Hypersensitivity
- Pregnancy
- Lactation
Common side effects
- Diarrhoea
- Nausea
- Headache
- Fatigue
Counselling Points
- Take once daily with or without food
- Monitor for liver function
- Use barrier contraception to prevent HIV transmission
Serious warnings
- Lactic acidosis
- Severe hepatomegaly
- Risk of hepatitis exacerbation
Important Disclaimer
The Tafbin 25mg. 200mg Tablet professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
